The 6th KOL & MSL Expertise Summit, held on February 26-27, 2025, in Philadelphia, convened professionals from the pharmaceutical and biotechnology sectors to delve into the evolving dynamics between Key Opinion Leaders (“KOLs”) and Medical Science Liaisons (“MSLs”). The summit offered a platform for in-depth discussions on enhancing collaboration, refining insight programs, and aligning strategies with business objectives.
Key Sessions and Speakers:
Build Core Competencies in Business Acumen and Strategic Thinking: Adeola Davis, Director of Learning & Development, Medical Affairs, Acadia Pharma, discussed strategies to enhance MSLs’ understanding of business operations, fostering a collaborative mindset aligned with corporate objectives.
Elevate MSL Performance with Well-Structured Collaborations with Medical Information Teams: Jason Bain, Medical Science Liaison, Exact Sciences, highlighted the importance of integrating Medical Information scientists into product teams to expedite responses to complex inquiries and improve partnership structures.
PANEL: Determine the Top Priorities for a Successful Insight Program: This panel focused on training MSLs to effectively gather and analyze insights, setting new standards for scientific exchange. Panelists included:
- Carl De Luca, Director, Field Medical Affairs – Oncology, Regeneron
- Ryan Van Puffelen, Senior Marketing Manager, KOL & Society Strategy, Johnson & Johnson
For those who could not attend, the summit is available on-demand, providing access to all sessions and discussions at your convenience.
